PHARMA MAR, S.A. «...678910...» Page 8 out of 23 31/05/2023 11:15 PHARMA MAR, S.A. Announcement of general shareholders’ meeting Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman and by the Chief Financial Officer of the Company. Register number: 22794 04/05/2023 09:04 PHARMA MAR, S.A. On business and financial situation Press release informing about the recruitment of the first patient in a new Phase I clinical trial for the treatment of patients with different types of solid tumors with its new molecule of marine origin: PM54 Register number: 22330 26/04/2023 18:12 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The Company announces the call of the Ordinary General Shareholders’ Meeting and submits proposed resolutions. Register number: 22126 26/04/2023 18:05 PHARMA MAR, S.A. On corporate governance The Company informs about the resignation of a director and changes in the composition of the Board of Directors and its Committees. Register number: 22124 26/04/2023 17:57 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company files first quarter 2023 financial information and announces a conference call with analysts and investors. Register number: 22122 17/04/2023 11:14 PHARMA MAR, S.A. Other relevant information The Executive Committee of Pharma Mar, S.A. has decided to implement the Free of Charge Stock Ownership Plan approved by resolution of the General Shareholders’ Meeting of 29 June 2022. Register number: 21950 11/04/2023 08:26 PHARMA MAR, S.A. On credit ratings Axesor maintains long-term credit rating of Pharma Mar. Register number: 21823 10/04/2023 16:48 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/01/2023 and 31/03/2023 Register number: 21817 08/03/2023 11:09 PHARMA MAR, S.A. On business and financial situation The Company announces the approval of Zepzelca® (lurbinectedin) for the treatment of metastatic Small Cell Lung Cancer in Switzerland Register number: 21210 28/02/2023 17:13 PHARMA MAR, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2022 Register number: 20971 Page 8 out of 23 «...678910...»
